Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 249 | 835 | 1,672 | 378 | 867 |
| Gross Profit | 249 | 835 | 1,672 | 378 | 867 |
| Operating Expenses | 130,421 | 127,070 | 129,090 | 122,643 | 122,916 |
| Operating Income | -130,172 | -126,235 | -127,418 | -122,265 | -122,049 |
| Interest Expense | 24,299 | 17,321 | 17,064 | 13,996 | 13,367 |
| Other Income | 11,153 | 7,913 | 7,586 | 6,839 | 6,779 |
| Pre-tax Income | -143,318 | -135,643 | -136,896 | -129,422 | -128,637 |
| Net Income Continuous | -143,318 | -135,643 | -136,896 | -129,422 | -128,637 |
| Net Income | $-143,318 | $-135,643 | $-136,896 | $-129,422 | $-128,637 |
| EPS Basic Total Ops | -1.31 | -1.33 | -1.38 | -1.35 | -1.34 |
| EPS Basic Continuous Ops | -1.31 | -1.33 | -1.38 | -1.35 | -1.34 |
| EPS Diluted Total Ops | -1.31 | -1.33 | -1.38 | -1.35 | -1.34 |
| EPS Diluted Continuous Ops | -1.31 | -1.33 | -1.38 | -1.35 | -1.34 |
| EPS Diluted Before Non-Recurring Items | -1.31 | -1.33 | -1.38 | N/A | N/A |
| EBITDA(a) | $-127,766 | $-123,904 | $-121,083 | $-120,411 | $-120,194 |